查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1114610

按診斷領域、模式、平台、最終用戶、地區劃分的全球即時檢測 (POCT) 市場：COVID-19 的影響、最新發展、公司概況 - 未來預測（至 2028 年）

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028
出版日期: | 出版商: iGate Research | 英文 270 Pages | 訂單完成後即時交付

價格

到 2028 年，全球即時檢測 (POCT) 市場預計將達到約 650 億美元。在過去 20 年中，隨著醫院內外對準確和快速檢測的需求不斷增加，床旁 (POC) 檢測呈指數級增長。 POCT 或床邊測試是一種醫學診斷測試，使醫生和醫務人員能夠在幾分鐘內獲得正確、實時、實驗室質量的診斷結果。

近年來，便攜式檢測設備的引入取得了進展，POC檢測已從醫院轉移到工作場所、家庭、災難，最近又轉移到便利店等各種醫療環境。此外，印度和中國等新興國家的傳染病、心血管疾病和糖尿病等慢性病發病率不斷上升，推動了對 POC 檢測服務的需求。因此，越來越多的傳染病和慢性病將在不久的將來加強即時檢測市場。

POCT 市場：按診斷細分市場預測

基於診斷細分市場，市場以血糖檢測細分市場為主。經濟體和發達國家糖尿病患病率的增加以及患者對家庭檢測的傾向增加是在預測期內推動該細分市場增長的主要驅動力。此外，傳染病部門在 2021 年佔第二大收入份額。另一方面，預計心臟標誌物部分將在預測期內出現顯著增長。

POCT 市場：按模式預測

按模式，市場以基於 POTC 的測試部分為主。由於其成本效益和易於操作，該細分市場在 2021 年將主導整個 POCT 市場。高細分增長率歸因於OTC測試數量的增加，例如血糖測試和妊娠測試，它們可以在幾秒鐘內提供結果。

POCT 市場：按平台預測

按平台劃分，橫向流動分析 (LFA) 部分將在 2021 年佔據最大的收入份額。基於側向流動分析的 POC 測試越來越多地被採用作為冗長的傳統實驗室流程的替代方案。此外，免疫分析技術 POCT 市場預計將在預測期內出現顯著增長。

POCT 市場：最終用戶預測

POCT 市場以醫院為主，其次是診所。隨著需要適當監測的慢性疾病（例如癌症和心血管疾病）的日益流行，醫院和診所需要微創手術。由於家庭和遠程監控的偏好日益增加以及家庭護理用戶對快速測試的需求不斷增加，預計家庭醫療保健部門在預測期內將呈現最高增長率。

POCT 市場：區域預測

按地區劃分，POCT 市場以北美為主，預計在預測期內將保持其地位。這是由於需要便攜式和快速診斷的慢性病和傳染病的流行率上升、產品批准的增加以及政府加大力度支持該地區採用 POCT。歐洲在 POCT 市場中佔有第二高的份額。由於老年人口的增加、目標疾病的患病率上升、家庭護理需求的增加以及先進技術的新產品的推出，亞太地區的 POCT 市場將在預測期內以最快的速度增長。預計

內容

第 1 章執行摘要

第 2 章 COVID-19 對全球即時檢測市場的影響

第 3 章全球即時檢測市場和預測（2010-2028 年）

第 4 章全球即時檢測市場份額和預測（2010-2028）

第 5 章全球即時檢測市場和預測：按診斷細分市場（2010-2028 年）

  • 血糖檢測
  • 心臟標誌物測試
  • 血脂/膽固醇測試
  • 凝血試驗
  • 傳染病測試
  • 尿液分析
  • 藥物濫用測試
  • 糞便潛血試驗
  • 妊娠和不孕檢查
  • 腫瘤標誌物檢測
  • 緊急救生檢查
  • HbA1c 測試
  • 臨床化學
  • 膽紅素測試
  • 驗血

第 6 章全球即時檢測市場和預測：按模式（2010-2028 年）

  • 基於處方的測試
  • 基於 OTC 的檢驗

第 7 章全球即時檢測市場和預測：按平台（2015-2028 年）

  • 橫向流動檢測
  • 免疫測定
  • 微流體
  • 油尺
  • 分子診斷
  • 其他平台

第 8 章全球即時檢測市場和預測：按最終用戶分類（2010-2028 年）

  • 醫院
  • 醫務室
  • 檢查室
  • 帶護理的住房
  • 居家護理

第 9 章全球即時檢測市場和預測：按地區劃分（2010-2028 年）

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第 10 章全球即時檢測市場：最新發展

第 11 章即時檢測市場：公司簡介

  • 雅培實驗室
    • 公司概況
    • 產品組合
    • 財務分析
    • 業務戰略
  • Siemens Healthineers
  • Roche Diagnostics
  • Quest Diagnostics
  • Becton, Dickinson and Company
  • ACON Laboratories
  • Abaxis, Inc.
  • Abingdon Health, Ltd.
  • Access Bio, Inc.
  • AccuBioTech Co, Ltd.
  • Akers Biosciences, Inc.
  • Alfa Scientific Designs, Inc
  • American Bio Medica Corporation
  • AmniSure International
  • Aquila Diagnostic Systems, Inc
  • ARKRAY Inc
  • Artron Laboratories Inc.
  • Ascensia Diabetes Care Holdings AG
  • Immune IQ (Formerly Ativa)
  • Atlas Link Biotech Co., Ltd
  • Audit Diagnostics
  • Augurix Diagnostics
  • Autobio Diagnostics Co., Ltd
  • Axxin
  • Beckman Coulter, Inc
  • Bhat Bio-Tech India Private Ltd. (BBI)
  • bioLytical Laboratories
  • BioMedomics, Inc
  • Biomerica, Inc.
  • bioMerieux SA
  • Biophor Diagnostics, Inc
  • Biosensia Ltd.
  • Bio-Rad Laboratories Inc.
  • Bioscan Screening Systems, Inc.
  • BTNX Inc.
  • Boditech Med Inc
  • Xiamen Boson Biotech Co. Ltd
  • Calypte Biomedical Corporation
  • Cepheid, Inc
  • Chembio Diagnostic Systems, Inc.
  • Clarity Diagnostics, LLC
  • Confirm Biosciences
  • CTK Biotech, Inc.
  • Daktari Diagnostics
  • Danaher Corporation
  • Dexcom, Inc
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc.
  • DNA Electronics Ltd. (DNAe)
  • EKF Diagnostics Holdings plc
  • ELITechGroup, Inc.
  • Eurolyser Diagnostica GmbH
  • Exact Sciences Corporation
  • Exalenz Bioscience Ltd.
  • Genedrive plc
  • GeTein BioMedical, Inc.
  • Helena Laboratories
  • Hemosure, Inc.
  • Immunostics, Inc.
  • Instrumentation Laboratory
  • JAL Innovation PTE LTD
  • Jant Pharmacal Corporation
  • LamdaGen Corporation
  • LifeScan, Inc
  • LifeSign, LLC
  • MBio Diagnostics, Inc (Now LightDeck Diagnostics)
  • Medix Biochemica
  • Medtronic, Inc.
  • A. Menarini Diagnostics S.R.L.
  • Meridian Bioscience, Inc
  • Nano-Ditech Corporation
  • Noble Medical, Inc
  • Nova Biomedical, Corp.
  • Oasis Diagnostics Corporation
  • OPKO Health, Inc
  • OPTI Medical Systems, Inc
  • OraSure Technologies, Inc
  • Polymed Therapeutics Inc.
  • Preventis GmbH
  • Princeton Biomeditech Corporation
  • QuantuMDx Group Limited
  • Radiometer Medical A/S
  • Response Biomedical Corp
  • Reszon Diagnostics International Sdn. Bhd.
  • Samsung Healthcare
  • Savyon Diagnostics
  • Sekisui Diagnostics LLC
  • Siloam Biosciences, Inc
  • Sysmex Corporation
  • TECHLAB, Inc.
  • Teco Diagnostics
  • Trinity Biotech PLC
  • Trividia Health
  • Tulip Diagnostics Ltd
  • Veredus Laboratories PTE Ltd
  • Vircell
  • WAMA Diagnostica
  • Wave 80 Biosciences
  • Werfen
  • Quidel Corporation
  • Thermo Fisher Scientific
  • Mesa Biotech Inc.
  • GeneSTAT Molecular Diagnostics, LLC
  • Biocartis Group NV
  • Johnson and Johnson Service, Inc.

第 12 章全球即時檢測市場：驅動因素

  • 床旁檢測：邁向未來的一步
  • 慢性病和傳染病的高發率
  • 繼續手動擴展 PoC（包括自檢）
    • 即時檢測的承諾
    • 即時檢測的可能性：“令人擔憂”
    • 中心和輻條
    • 教育
  • POCT技術進步拉動市場需求

第 13 章全球即時檢測市場：挑戰

  • 在低收入和中等收入國家進行即時 (POC) 檢測的障礙
    • 廣泛採用 PoC 技術的障礙
    • 床旁檢測存在技術、管理和運營方面的障礙
    • 與衛生系統相關的即時檢測障礙
    • 即時檢測的經濟障礙
  • 政策/監管指南和資金挑戰
  • PoC 診斷開發中的基礎設施障礙和挑戰

The global point of care testing (POCT) market is predicted to reach nearly US$ 65 Billion by 2028. Point-of-care (POC) testing has skyrocketed in the last 20 years as demand for accurate and fast testing has blossomed both inside and outside the hospital setting. POCT or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours.

Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. Furthermore, rising incidence of infectious diseases and chronic conditions such as cardiovascular diseases and diabetes in developing countries such as India and China have stimulated demand for point of care testing services. As per statistics of the International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years) are living with diabetes globally, and it is estimated to reach 643 million by 2030 and 783 million by 2045. Hence, growing infectious diseases and chronic conditions will enhance the point of care testing market in the near future.

Impact of COVID-19 on Global Point of Care Testing Market

The COVID-19 outbreak has become a global stress test. The disease has infected around 596.2 million people worldwide. Globally the death toll has reached 6,456,879 according to the latest statistics from the Worldometers (as of August 16, 2022). The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak stirred an unprecedented public health concern across the globe and has positively impacted the point of care testing market growth.

The need for speedy diagnostic results has made point-of-care testing a vital diagnostic tool. The novel coronavirus has accelerated the research and development activities in the point-of-care diagnostics market. The usage of POC kits in COVID-19 diagnosis has increased at a significant pace owing to multiple advantages such as smaller size, portability, convenience, and precise outcomes, among others. These tests are capable of operating in any low-resource setting including home care settings and are needed to adequately combat the COVID-19 pandemic.

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment. Increasing prevalence of diabetes in developing as well as developed economies and the rising inclination of patients towards home testing is the major driver that will drive segmental growth over the forecast timeframe.

The infectious diseases segment held second largest revenue share in 2021. Infectious diseases are the primary cause of mortality globally, and according to figures from the Clinical Microbiology and Infection journal, they claim over 14 million lives annually, making up around 25% of the 56 million deaths recorded worldwide. Infectious disease testing has shifted from centralized to decentralized POC testing, resulting in better patient care. The market is being driven by increased demand for quick tests, which has prompted industry players to deliver POC solutions to decentralized regions. For instance, Abbott has introduced ID NOW, the world's quickest molecular POC test, which provides COVID-19 findings in 13 minutes and is usable in a variety of decentralized healthcare settings.

Cardiac marker segment is expected to grow at a significant rate during the forecast period. The growing prevalence of cardiovascular ailments, increasing purchasing power, rise in the geriatric population, associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in rural areas is expected to drive the market for cardiac markers.

By Mode - Global Point of Care Testing Market & Forecast

On the basis of mode, the point of care testing market is dominated by OTC-based testing segment. The segment is dominating the overall POCT market in 2021 as these tests are cost-effective as well as easy operative in nature. High segmental growth is attributed to rising number of OTC testing such as blood glucose tests and pregnancy tests that provides result in few seconds. These tests do not require skilled professional to perform and can be self-tested by individuals, thereby boosting the market growth. The Prescription based testing segment is expected to grow at the highest rate during the forecast period.

By Platform - Global Point of Care Testing Market & Forecast

By platform, the Lateral Flow Assays (LFA) segment accounted for largest revenue share in 2021. POC tests based on lateral flow assays are increasingly being employed to replace long, conventional laboratory processes. Lateral flow assays are simple devices used to detect the presence or absence of target analytes in samples. These assays help in detecting and quantifying analytes in complex mixtures and provide results within 30 minutes after the sample is placed on the device. The point of care testing market for immunoassays technology is expected to witness significant growth over the forecast timeframe. Rapid immunoassays improve quality of care through its performance at point of care facilities, such as student health clinics, labor and delivery suites and emergency rooms. The cost-effectiveness offered by these immunoassays will influence segment growth during the forecast period.

By End Users - Global Point of Care Testing Market & Forecast

Based on end users, the point of care testing market is segmented into Hospitals, Clinics, Laboratories, Home Care and Assisted Living Healthcare Facilities. Hospitals held majority of the point of care testing market, followed by Clinics. Increase in prevalence of chronic conditions such as cancer and cardiovascular diseases that require proper monitoring and prefer minimally invasive procedures are carried out in hospitals and clinics. The home care segment is expected to grow at the highest rate during the forecast period driven by increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.

By Region - Global Point of Care Testing Market & Forecast

The point of care testing market, by region, is dominated by North America and is expected to maintain its position throughout the forecast period. This can be attributed to rising prevalence of chronic disorders and infectious diseases, which need portable and rapid diagnosis, increasing number of product approvals, and rising government initiatives to support the adoption of POCT in this region. Europe held second highest share of the point of care testing market. Asia-Pacific point of care testing market is expected to grow at the fastest rate during the forecast period driven by growing geriatric population base, rising prevalence of target diseases, increasing demand for home healthcare and the introduction of new products enabled with advanced technologies.

iGATE RESEARCH report titled "Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028" provides a comprehensive analysis of the Global Point of Care Testing Market.

This 270 Page report with 78 Figures and 12 Tables has been analyzed from 11 View Points:

1) Global - Point of Care Testing Market & Forecast (2010 - 2028)

2) Impact of COVID-19 on Global Point of Care Testing Market

3) Global - Point of Care Testing Market Share and Forecast (2010 - 2028)

4) By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)

5) By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)

6) By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)

7) By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)

8) By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)

9) Global Point of Care Testing Market - Recent Developments

10) Global Point of Care Testing Market - 106 Company Profiles

11) Global Point of Care Testing Market - Growth Drivers & Challenges

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

1. Blood Glucose Testing

2. Cardiac Marker Testing

3. Lipid Panel/Cholesterol Testing

4. Coagulation Testing

5. Infectious Disease Testing

6. Urinalysis Testing

7. Drug of Abuse Testing

8. Fecal Occult Blood Testing

9. Pregnancy & Fertility Testing

10. Tumor Marker Testing

11. Critical Care Testing

12. HbA1c Testing

13. Clinical Chemistry Testing

14. Bilirubin Testing

15. Hematology Testing

By Mode - Global Point of Care Testing Market & Forecast

  • Prescription-based Testing
  • OTC-based Testing

By Platform - Global Point of Care Testing Market & Forecast

  • Lateral Flow Assays
  • Immunoassays
  • Microfluidics
  • Dipsticks
  • Molecular Diagnostics
  • Others

By End Users - Global Point of Care Testing Market & Forecast

1. Hospitals

2. Clinics

3. Laboratories

4. Assisted Living Healthcare Facilities

5. Home Care

By Region - Global Point of Care Testing Market & Forecast

1. North America

2. Europe

3. Asia Pacific

4. Latin America

5. Middle East & Africa

Global Point of Care Testing Market - 106 Company Profiles

1. Abbott Laboratories 2. Siemens Healthineers 3. Roche Diagnostics 4. Quest Diagnostics 5. Becton, Dickinson and Company 6. ACON Laboratories 7. Abaxis, Inc 8. Abingdon Health, Ltd 9. Access Bio, Inc. 10. AccuBioTech Co, Ltd. 11. Akers Biosciences, Inc. 12. Alfa Scientific Designs, Inc 13. American Bio Medica Corporation 14. AmniSure International 15. Aquila Diagnostic Systems, Inc 16. ARKRAY Inc 17. Artron Laboratories Inc. 18. Ascensia Diabetes Care Holdings AG 19. Immune IQ (Formerly Ativa) 20. Atlas Link Biotech Co., Ltd 21. Audit Diagnostics 22. Augurix Diagnostics 23. Autobio Diagnostics Co., Ltd 24. Axxin 25. Beckman Coulter, Inc 26. Bhat Bio-Tech India Private Ltd. 27. bioLytical Laboratories 28. BioMedomics, Inc 29. Biomerica, Inc. 30. bioMerieux SA 31. Biophor Diagnostics, Inc 32. Bio-Rad Laboratories Inc. 33. Bioscan Screening Systems, Inc. 34. Biosensia Ltd. 35. BTNX Inc. 36. Boditech Med Inc 37. Xiamen Boson Biotech Co. Ltd 38. Calypte Biomedical Corporation 39. Cepheid, Inc 40. Chembio Diagnostic Systems, Inc 41. Clarity Diagnostics, LLC 42. Confirm Biosciences 43. CTK Biotech, Inc. 44. Daktari Diagnostics 45. Danaher Corporation 46. Dexcom, Inc 47. DIALAB GmbH 48. DiaSys Diagnostic Systems GmbH 49. Diazyme Laboratories, Inc. 50. DNA Electronics Ltd. (DNAe) 51. EKF Diagnostics Holdings plc 52. ELITechGroup, Inc. 53. Eurolyser Diagnostica GmbH 54. Exact Sciences Corporation 55. Exalenz Bioscience Ltd 56. Genedrive plc 57. GeTein BioMedical, Inc. 58. Helena Laboratories 59. Hemosure, Inc. 60. Immunostics, Inc. 61. Instrumentation Laboratory 62. JAL Innovation PTE LTD 63. Jant Pharmacal Corporation 64. LamdaGen Corporation 65. LifeScan, Inc 66. LifeSign, LLC 67. MBio Diagnostics, Inc (Now LightDeck Diagnostics) 68. Medix Biochemica 69. Medtronic, Inc 70. A. Menarini Diagnostics S.R.L. 71. Meridian Bioscience, Inc 72. Nano-Ditech Corporation 73. Noble Medical, Inc 74. Nova Biomedical, Corp. 75. Oasis Diagnostics Corporation 76. OPKO Health, Inc 77. OPTI Medical Systems, Inc 78. OraSure Technologies, Inc 79. Polymed Therapeutics Inc. 80. Preventis GmbH 81. Princeton Biomeditech Corporation 82. QuantuMDx Group Limited 83. Radiometer Medical A/S 84. Response Biomedical Corp 85. Reszon Diagnostics International Sdn. Bhd. 86. Samsung Healthcare 87. Savyon Diagnostics 88. Sekisui Diagnostics LLC 89. Siloam Biosciences, Inc 90. Sysmex Corporation 91. TECHLAB, Inc. 92. Teco Diagnostics 93. Trinity Biotech PLC 94. Trividia Health 95. Tulip Diagnostics Ltd 96. Veredus Laboratories PTE Ltd 97. Vircell 98. WAMA Diagnostica 99. Wave 80 Biosciences 100. Werfen 101. Quidel Corporation 102. Thermo Fisher Scientific 103. Mesa Biotech Inc 104. GeneSTAT Molecular Diagnostics, LLC 105. Biocartis Group NV 106. Johnson and Johnson Service, Inc.

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Point of Care Testing Market

3. Global - Point of Care Testing Market & Forecast (2010 - 2028)

4. Global - Point of Care Testing Market Share & Forecast (2010 - 2028)

  • 4.1 By Diagnostics Segment - Global Point of Care Testing Market Share & Forecast
  • 4.2 By Mode - Global Point of Care Testing Market Share & Forecast
  • 4.3 By Platform - Global Point of Care Testing Market Share & Forecast (2015 - 2028)
  • 4.4 By End Users - Global Point of Care Testing Market Share & Forecast
  • 4.5 By Region - Point of Care Testing Market Share & Forecast

5. By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)

  • 5.1 Blood Glucose Testing Market & Forecast
  • 5.2 Cardiac Marker Testing Market & Forecast
  • 5.3 Lipid Panel/Cholesterol Testing Market & Forecast
  • 5.4 Coagulation Testing Market & Forecast
  • 5.5 Infectious Disease Testing Market & Forecast
  • 5.6 Urinalysis Testing Market & Forecast
  • 5.7 Drug of Abuse Testing Market & Forecast
  • 5.8 Fecal Occult Blood Testing Market & Forecast
  • 5.9 Pregnancy & Fertility Testing Market & Forecast
  • 5.10 Tumor Marker Testing Market & Forecast
  • 5.11 Critical Care Testing Market & Forecast
  • 5.12 HbA1c Testing Market & Forecast
  • 5.13 Clinical Chemistry Testing Market & Forecast
  • 5.14 Bilirubin Testing Market & Forecast
  • 5.15 Hematology Testing Market & Forecast

6. By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)

  • 6.1 Prescription-based Testing Market & Forecast
  • 6.2 OTC-based Testing Market & Forecast

7. By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)

  • 7.1 Global - Point of Care Diagnostics Market for Lateral Flow Assays
  • 7.2 Global - Point of Care Diagnostics Market for Immunoassays
  • 7.3 Global - Point of Care Diagnostics Market for Microfluidics
  • 7.4 Global - Point of Care Diagnostics Market for Dipsticks
  • 7.5 Global - Point of Care Diagnostics Market for Molecular Diagnostics
  • 7.6 Global - Point of Care Diagnostics Market for Other Platforms

8. By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)

  • 8.1 Hospitals - Point of Care Testing Market & Forecast
  • 8.2 Clinics - Point of Care Testing Market & Forecast
  • 8.3 Laboratories - Point of Care Testing Market & Forecast
  • 8.4 Assisted Living Healthcare Facilities - Point of Care Testing Market & Forecast
  • 8.5 Home Care - Point of Care Testing Market & Forecast

9. By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)

  • 9.1 North America - Point of Care Testing Market & Forecast
  • 9.2 Europe - Point of Care Testing Market & Forecast
  • 9.3 Asia Pacific - Point of Care Testing Market & Forecast
  • 9.4 Latin America - Point of Care Testing Market & Forecast
  • 9.5 Middle East and Africa - Point of Care Testing Market & Forecast

10. Global Point of Care Testing Market - Recent Developments

11. Point of Care Testing Market - Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Company Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Financial Insight
    • 11.1.4 Business Strategy
  • 11.2 Siemens Healthineers
    • 11.2.1 Company Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Financial Insight
    • 11.2.4 Business Strategy
  • 11.3 Roche Diagnostics
    • 11.3.1 Company Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Financial Insight
    • 11.3.4 Business Strategy
  • 11.4 Quest Diagnostics
    • 11.4.1 Company Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Financial Insight
    • 11.4.4 Business Strategy
  • 11.5 Becton, Dickinson and Company
    • 11.5.1 Company Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Financial Insight
    • 11.5.4 Business Strategy
  • 11.6 ACON Laboratories
    • 11.6.1 Company Overview
    • 11.6.2 Product Portfolio
  • 11.7 Abaxis, Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Product Portfolio
  • 11.8 Abingdon Health, Ltd.
    • 11.8.1 Company Overview
    • 11.8.2 Product Portfolio
  • 11.9 Access Bio, Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Product Portfolio
  • 11.10 AccuBioTech Co, Ltd.
  • 11.11 Akers Biosciences, Inc.
  • 11.12 Alfa Scientific Designs, Inc
  • 11.13 American Bio Medica Corporation
  • 11.14 AmniSure International
  • 11.15 Aquila Diagnostic Systems, Inc
  • 11.16 ARKRAY Inc
  • 11.17 Artron Laboratories Inc.
  • 11.18 Ascensia Diabetes Care Holdings AG
  • 11.19 Immune IQ (Formerly Ativa)
  • 11.20 Atlas Link Biotech Co., Ltd
  • 11.21 Audit Diagnostics
  • 11.22 Augurix Diagnostics
  • 11.23 Autobio Diagnostics Co., Ltd
  • 11.24 Axxin
  • 11.25 Beckman Coulter, Inc
  • 11.26 Bhat Bio-Tech India Private Ltd. (BBI)
  • 11.27 bioLytical Laboratories
  • 11.28 BioMedomics, Inc
  • 11.29 Biomerica, Inc.
  • 11.30 bioMerieux SA
  • 11.31 Biophor Diagnostics, Inc
  • 11.32 Biosensia Ltd.
  • 11.33 Bio-Rad Laboratories Inc.
  • 11.34 Bioscan Screening Systems, Inc.
  • 11.35 BTNX Inc.
  • 11.36 Boditech Med Inc
  • 11.37 Xiamen Boson Biotech Co. Ltd
  • 11.38 Calypte Biomedical Corporation
  • 11.39 Cepheid, Inc
  • 11.40 Chembio Diagnostic Systems, Inc.
  • 11.41 Clarity Diagnostics, LLC
  • 11.42 Confirm Biosciences
  • 11.43 CTK Biotech, Inc.
  • 11.44 Daktari Diagnostics
  • 11.45 Danaher Corporation
  • 11.46 Dexcom, Inc
  • 11.47 DIALAB GmbH
  • 11.48 DiaSys Diagnostic Systems GmbH
  • 11.49 Diazyme Laboratories, Inc.
  • 11.50 DNA Electronics Ltd. (DNAe)
  • 11.51 EKF Diagnostics Holdings plc
  • 11.52 ELITechGroup, Inc.
  • 11.53 Eurolyser Diagnostica GmbH
  • 11.54 Exact Sciences Corporation
  • 11.55 Exalenz Bioscience Ltd.
  • 11.56 Genedrive plc
  • 11.57 GeTein BioMedical, Inc.
  • 11.58 Helena Laboratories
  • 11.59 Hemosure, Inc.
  • 11.60 Immunostics, Inc.
  • 11.61 Instrumentation Laboratory
  • 11.62 JAL Innovation PTE LTD
  • 11.63 Jant Pharmacal Corporation
  • 11.64 LamdaGen Corporation
  • 11.65 LifeScan, Inc
  • 11.66 LifeSign, LLC
  • 11.67 MBio Diagnostics, Inc (Now LightDeck Diagnostics)
  • 11.68 Medix Biochemica
  • 11.69 Medtronic, Inc.
  • 11.70 A. Menarini Diagnostics S.R.L.
  • 11.71 Meridian Bioscience, Inc
  • 11.72 Nano-Ditech Corporation
  • 11.73 Noble Medical, Inc
  • 11.74 Nova Biomedical, Corp.
  • 11.75 Oasis Diagnostics Corporation
  • 11.76 OPKO Health, Inc
  • 11.77 OPTI Medical Systems, Inc
  • 11.78 OraSure Technologies, Inc
  • 11.79 Polymed Therapeutics Inc.
  • 11.80 Preventis GmbH
  • 11.81 Princeton Biomeditech Corporation
  • 11.82 QuantuMDx Group Limited
  • 11.83 Radiometer Medical A/S
  • 11.84 Response Biomedical Corp
  • 11.85 Reszon Diagnostics International Sdn. Bhd.
  • 11.86 Samsung Healthcare
  • 11.87 Savyon Diagnostics
  • 11.88 Sekisui Diagnostics LLC
  • 11.89 Siloam Biosciences, Inc
  • 11.90 Sysmex Corporation
  • 11.91 TECHLAB, Inc.
  • 11.92 Teco Diagnostics
  • 11.93 Trinity Biotech PLC
  • 11.94 Trividia Health
  • 11.95 Tulip Diagnostics Ltd
  • 11.96 Veredus Laboratories PTE Ltd
  • 11.97 Vircell
  • 11.98 WAMA Diagnostica
  • 11.99 Wave 80 Biosciences
  • 11.100 Werfen
  • 11.101 Quidel Corporation
  • 11.102 Thermo Fisher Scientific
  • 11.103 Mesa Biotech Inc.
  • 11.104 GeneSTAT Molecular Diagnostics, LLC
  • 11.105 Biocartis Group NV
  • 11.106 Johnson and Johnson Service, Inc.

12. Global Point of Care Testing Market - Growth Drivers

  • 12.1 Point-of-care Testing: A Step to the Future
  • 12.2 High Prevalence of Chronic and Infectious Diseases
  • 12.3 Continued Expansion of Point of Care Including Self Testing
    • 12.3.1 The Promise of Point-of-Care Testing
    • 12.3.2 Future of Point of Care Testing - The 'Worried Well'
    • 12.3.3 Hub and Spoke
    • 12.3.4 Education
  • 12.4 Technological Advancement in POCT to Spur Market Demand

13. Global Point of Care Testing Market - Challenges

  • 13.1 Point of Care (POC) Testing Barriers in Low & Middle-Income Countries
    • 13.1.1 Barriers to Adoption & Scale-up of POC Technologies
    • 13.1.2 Technical, Administrative & Operational Barriers of Point of Care Tests
    • 13.1.3 Health System Related Barriers of Point of Care Tests
    • 13.1.4 Economic Barriers of Point of Care Tests
  • 13.2 Policy/Regulatory Guidelines and Funding Challenges
  • 13.3 Infrastructure Barriers and Challenges with POC Diagnostics Development

List of Figures

List of Figures:

  • Figure 3-1: Global - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 3-2: Global - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 5-1: Global - Blood Glucose Testing Market (Million US$), 2010 - 2021
  • Figure 5-2: Global - Forecast for Blood Glucose Testing Market (Million US$), 2022 - 2028
  • Figure 5-3: Global - Cardiac Marker Testing Market (Million US$), 2010 - 2021
  • Figure 5-4: Global - Forecast for Cardiac Marker Testing Market (Million US$), 2022 - 2028
  • Figure 5-5: Global - Lipid Panel/Cholesterol Testing Market (Million US$), 2010 - 2021
  • Figure 5-6: Global - Forecast for Lipid Panel/Cholesterol Testing Market (Million US$), 2022 - 2028
  • Figure 5-7: Global - Coagulation Testing Market (Million US$), 2010 - 2021
  • Figure 5-8: Global - Forecast for Coagulation Testing Market (Million US$), 2022 - 2028
  • Figure 5-9: Global - Infectious Disease Testing Market (Million US$), 2010 - 2021
  • Figure 5-10: Global - Forecast for Infectious Disease Testing Market (Million US$), 2022 - 2028
  • Figure 5-11: Global - Urinalysis Testing Market (Million US$), 2010 - 2021
  • Figure 5-12: Global - Forecast for Urinalysis Testing Market (Million US$), 2022 - 2028
  • Figure 5-13: Global - Drug of Abuse Testing Market (Million US$), 2010 - 2021
  • Figure 5-14: Global - Forecast for Drug of Abuse Testing Market (Million US$), 2022 - 2028
  • Figure 5-15: Global - Fecal Occult Blood Testing Market (Million US$), 2010 - 2021
  • Figure 5-16: Global - Forecast for Fecal Occult Blood Testing Market (Million US$), 2022 - 2028
  • Figure 5-17: Global - Pregnancy & Fertility Testing Market (Million US$), 2010 - 2021
  • Figure 5-18: Global - Forecast for Pregnancy & Fertility Testing Market (Million US$), 2022 - 2028
  • Figure 5-19: Global - Tumor Marker Testing Market (Million US$), 2010 - 2021
  • Figure 5-20: Global - Forecast for Tumor Marker Testing Market (Million US$), 2022 - 2028
  • Figure 5-21: Global - Critical Care Testing Market (Million US$), 2010 - 2021
  • Figure 5-22: Global - Forecast for Critical Care Testing Market (Million US$), 2022 - 2028
  • Figure 5-23: Global - HbA1c Testing Market (Million US$), 2010 - 2021
  • Figure 5-24: Global - Forecast for HbA1c Testing Market (Million US$), 2022 - 2028
  • Figure 5-25: Global - Clinical Chemistry Testing Market (Million US$), 2010 - 2021
  • Figure 5-26: Global - Forecast for Clinical Chemistry Testing Market (Million US$), 2022 - 2028
  • Figure 5-27: Global - Bilirubin Testing Market (Million US$), 2010 - 2021
  • Figure 5-28: Global - Forecast for Bilirubin Testing Market (Million US$), 2022 - 2028
  • Figure 5-29: Global - Hematology Testing Market (Million US$), 2010 - 2021
  • Figure 5-30: Global - Forecast for Hematology Testing Market (Million US$), 2022 - 2028
  • Figure 6-1: Global - Prescription-based Testing Market (Million US$), 2010 - 2021
  • Figure 6-2: Global - Forecast for Prescription-based Testing Market (Million US$), 2022 - 2028
  • Figure 6-3: Global - OTC-based Testing Market (Million US$), 2010 - 2021
  • Figure 6-4: Global - Forecast for OTC-based Testing Market (Million US$), 2022 - 2028
  • Figure 7-1: Global POCT - Lateral Flow Assays Market (Million US$), 2015 - 2021
  • Figure 7-2: Global POCT - Forecast for Lateral Flow Assays Market (Million US$), 2022 - 2028
  • Figure 7-3: Global POCT - Immunoassays Market (Million US$), 2015 - 2021
  • Figure 7-4: Global POCT - Forecast for Immunoassays Market (Million US$), 2022 - 2028
  • Figure 7-5: Global POCT - Microfluidics Market (Million US$), 2015 - 2021
  • Figure 7-6: Global POCT - Forecast for Microfluidics Market (Million US$), 2022 - 2028
  • Figure 7-7: Global POCT - Dipsticks Market (Million US$), 2015 - 2021
  • Figure 7-8: Global POCT - Forecast for Dipsticks Market (Million US$), 2022 - 2028
  • Figure 7-9: Global POCT - Molecular Diagnostics Market (Million US$), 2015 - 2021
  • Figure 7-10: Global POCT - Forecast for Molecular Diagnostics Market (Million US$), 2022 - 2028
  • Figure 7-11: Global POCT - Other Platforms Market (Million US$), 2015 - 2021
  • Figure 7-12: Global POCT - Forecast for Other Platforms Market (Million US$), 2022 - 2028
  • Figure 8-1: Hospitals - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 8-2: Hospitals - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 8-3: Clinics - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 8-4: Clinics - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 8-5: Laboratories - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 8-6: Laboratories - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 8-7: Assisted Living Healthcare Facilities - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 8-8: Assisted Living Healthcare Facilities - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 8-9: Home Care - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 8-10: Home Care - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 9-1: North America - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 9-2: North America - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 9-3: Europe - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 9-4: Europe - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 9-5: Asia Pacific - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 9-6: Asia Pacific - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 9-7: Latin America - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 9-8: Latin America - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 9-9: Middle East and Africa - Point of Care Testing Market (Million US$), 2010 - 2021
  • Figure 9-10: Middle East and Africa - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
  • Figure 11-1: Abbott Laboratories - Global Diagnostics Sales (Million US$), 2013 - 2021
  • Figure 11-2: Abbott Laboratories - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
  • Figure 11-3: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2013 - 2021
  • Figure 11-4: Siemens Healthineers - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
  • Figure 11-5: Roche Diagnostics - Global Sales (Million US$), 2013 - 2021
  • Figure 11-6: Roche Diagnostics - Forecast for Global Sales (Million US$), 2022 - 2028
  • Figure 11-7: Quest Diagnostics - Net Sales (Million US$), 2014 - 2021
  • Figure 11-8: Quest Diagnostics - Forecast for Net Sales (Million US$), 2022 - 2028
  • Figure 11-9: Becton, Dickinson and Company - Global Diagnostics Sales (Million US$), 2014 - 2021
  • Figure 11-10: Becton, Dickinson and Company - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028

List of Tables:

  • Table 4-1: By Diagnostics Segment - Global Point of Care Testing Market Share (Percent), 2010 - 2021
  • Table 4-2: By Diagnostics Segment - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
  • Table 4-3: By Mode - Global Point of Care Testing Market Share (Percent), 2010 - 2021
  • Table 4-4: By Mode - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
  • Table 4-5: By Platform - Global Point of Care Testing Market Share (Percent), 2015 - 2021
  • Table 4-6: By Platform - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
  • Table 4-7: By End Users - Global Point of Care Testing Market Share (Percent), 2010 - 2021
  • Table 4-8: By End Users - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
  • Table 4-9: By Region - Point of Care Testing Market Share (Percent), 2010 - 2021
  • Table 4-10: By Region - Forecast for Point of Care Testing Market Share (Percent), 2022 - 2028
  • Table 11-1: Eurolyser Diagnostica GmbH - Point-of-Care Test Portfolio
  • Table 13-1: POCT - Barriers to Adoption and Scale-up of POC Technologies